Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
125.00
-6.79 (-5.15%)
Aug 1, 2025, 3:56 PM EDT
Merck KGaA Market Cap
Merck KGaA has a market cap or net worth of $53.79 billion as of August 1, 2025. Its market cap has decreased by -24.22% in one year.
Market Cap
53.79B
Enterprise Value
62.05B
Revenue
23.04B
Ranking
n/a
PE Ratio
17.66
Stock Price
$125.00
Market Cap Chart
Since April 7, 1997, Merck KGaA's market cap has increased from 6.76B to 53.79B, an increase of 695.41%. That is a compound annual growth rate of 7.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 53.79B | -14.77% |
| Dec 30, 2024 | 63.11B | -8.87% |
| Dec 29, 2023 | 69.25B | -17.61% |
| Dec 30, 2022 | 84.06B | -24.78% |
| Dec 30, 2021 | 111.75B | 49.03% |
| Dec 30, 2020 | 74.98B | 45.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 396.28M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 366.82M |
| Northwest Biotherapeutics | 361.28M |